• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Restenosis (4576)
Event Date 02/10/2021
Event Type  Injury  
Manufacturer Narrative
Journal title: estimated glomerular filtration rate as a predictor of restenosis after carotid stenting using first-generation stents doi: 10.1177/00033197211014684.Age: average.Sex: majority gender.Event date: date of publication.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article was submitted detailing a single-center retrospective database analysis study which evaluated the impact of the baseline estimated glomerular filtration rate (egfr) on clinical and angiographic outcomes and long-term in-stent restenosis (isr) rates in patients undergoing elective carotid artery stenting (cas) procedures.Medtronic¿s spider fx distal embolic protection device was used when crossing the lesion.Medtronic¿s protégé rx self-expanding stents the endovascular cas procedure.477 cas procedures were evaluated for enrolment in the study.33 patient deaths are reported during the 3-year follow-up period resulting from exclusion from the study.Other reasons for exclusion included patients lost to follow-up.The study population remained at 405, in which 38 protégé rx stents were implanted.Pre-dilation was performed in 40 patients, and post dilation performed in 93.6% pf patients.In-stent restenosis is reported in 44 patients throughout the follow-up period.The overall death rate was reported as 7.5% of the study group over the three years.There is no established or suspected causal relationship between the device(s) and the death events.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE RX CAROTID STENT SYSTEM
Type of Device
STENT, CAROTID
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key12486547
MDR Text Key272671739
Report Number2183870-2021-00340
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
P060001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/17/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/28/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age68 YR
Patient SexMale
-
-